Including Indirect Medical Care Costs from Survivor Years of Life in Economic Evaluations

Author： Nyman John A.   Jalal Hawre J.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.29, Iss.3, 2011-03, pp. : 173-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Standardizing the Inclusion of Indirect Medical Costs in Economic Evaluations

By van Baal Pieter H.M.   Wong Albert   Slobbe Laurentius C.J.  

PharmacoEconomics, Vol. 29, Iss. 3, 2011-03 ,pp. : 175-187

Adis International

Access to resources Recommend Favorite

Unrelated Medical Costs in Life-Years Gained: Should They be Included in Economic Evaluations of Healthcare Interventions?

By Rappange David R.  

PharmacoEconomics, Vol. 26, Iss. 10, 2008-01 ,pp. : 815-830

Adis International

Access to resources Recommend Favorite

How to Calculate Indirect Costs in Economic Evaluations

By Liljas B.  

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 1-7

Adis International

Access to resources Recommend Favorite

How to Calculate Indirect Costs in Economic Evaluations

By Brouwer W.B.F.   Koopmanschap M.A.  

PharmacoEconomics, Vol. 13, Iss. 5, 1998-05 ,pp. : 563-569

Adis International

Access to resources Recommend Favorite

Years of Potential Life Lost and Indirect Costs of Melanoma and Non-Melanoma Skin Cancer: A Systematic Review of the Literature

By GuyJr Gery P.   Ekwueme Donatus U.  

PharmacoEconomics, Vol. 29, Iss. 10, 2011-10 ,pp. : 863-874

Adis International

Access to resources Recommend Favorite